WhichPepsPeptides. Without the hype.
Human evidence record ยท Thymalin

Thymalin added to standard treatment in non-specific pulmonary disease

Thymalin was associated with normalization of lymphocyte count and OKT-4+/OKT-8+ subpopulations; little effect was reported on several other immune measures.

Quick read
Human evidence record

What this study tells us

This study compared groups, which is more informative than an uncontrolled report. The amount of confidence still depends on how the groups were formed, how outcomes were measured and how well bias was controlled.

Who was studied?

Patients with non-specific pulmonary diseases

How many?

n=35

What happened?

Thymalin was associated with normalization of lymphocyte count and OKT-4+/OKT-8+ subpopulations; little effect was reported on several other immune measures.

What stops us overclaiming?

Very small, old Russian study; surrogate immune endpoints and limited generalizability.

Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary โ†’

Key result

Thymalin was associated with normalization of lymphocyte count and OKT-4+/OKT-8+ subpopulations; little effect was reported on several other immune measures.

Study details

Study designSmall controlled clinical study
PopulationPatients with non-specific pulmonary diseases
Sample size35
RouteInjection
Regimen / exposure21 received Thymalin plus standard treatment; 14 control; 4-6 injections reported
DurationTreatment course
ComparatorStandard treatment control
Primary endpoint / questionCellular immune markers and clinical course
Safety resultModern adverse-event reporting was not provided.
Key limitationsVery small, old Russian study; surrogate immune endpoints and limited generalizability.
Registry / identifierPMID 2741122